{"id":219793,"date":"2026-08-26T14:47:37","date_gmt":"2026-08-26T09:17:37","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=219793"},"modified":"2026-08-26T14:47:38","modified_gmt":"2026-08-26T09:17:38","slug":"honasa-consumer-share-price-fluence-pharma-deal-exit-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/","title":{"rendered":"Honasa Consumer Share Price Falls 1.93% as Company Calls Off Proposed 58% Stake Acquisition in Fluence Pharma on August 26, 2026"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Honasa Consumer (HONASA) at Rs 476.15, -1.93% on Aug 26. Calls off 58% stake acquisition in Fluence Pharma. Intraday range Rs 475.30-488.00. Nutraceutical strategy maintained.<\/em><\/p>\n<div style=\"background: #F0F9FF; border-left: 4px solid #2E7D32; padding: 12px 16px; margin: 16px 0;\">\n<p><strong>Quick Answer:<\/strong> Why is Honasa Consumer share price falling today?<\/p>\n<p>Honasa Consumer share price fell 1.93% to Rs 476.15 on August 26, 2026 after the company announced it has called off the proposed acquisition of a 58% stake in Fluence Pharma. The deal was terminated due to non-fulfilment of closing conditions specified under the Share Purchase Agreement (SPA). The company said it remains committed to its nutraceutical strategy and will continue to evaluate the right opportunities, both organic and inorganic, to build a strong consumer-focused business in this category.<\/p>\n<\/div>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=honasa-fluence-deal-off\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#About_Honasa_Consumer_Mamaearth\" title=\"About Honasa Consumer (Mamaearth)\">About Honasa Consumer (Mamaearth)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#Why_Did_the_Fluence_Pharma_Deal_Fall_Through\" title=\"Why Did the Fluence Pharma Deal Fall Through?\">Why Did the Fluence Pharma Deal Fall Through?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#Market_Reaction_Why_Is_the_Stock_Falling\" title=\"Market Reaction: Why Is the Stock Falling?\">Market Reaction: Why Is the Stock Falling?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#Honasa_Consumer_Stock_Data\" title=\"Honasa Consumer Stock Data\">Honasa Consumer Stock Data<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#What_Honasa_Consumers_Nutraceutical_Strategy_Means_Going_Forward\" title=\"What Honasa Consumer&#8217;s Nutraceutical Strategy Means Going Forward\">What Honasa Consumer&#8217;s Nutraceutical Strategy Means Going Forward<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#Key_Risks_for_Honasa_Consumer_Investors\" title=\"Key Risks for Honasa Consumer Investors\">Key Risks for Honasa Consumer Investors<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#Nutraceutical_Entry_Timeline_Delayed\" title=\"Nutraceutical Entry Timeline Delayed\">Nutraceutical Entry Timeline Delayed<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#Core_Business_Competition\" title=\"Core Business Competition\">Core Business Competition<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#Frequently_Asked_Questions_on_Honasa_Consumer_Share_Price\" title=\"Frequently Asked Questions on Honasa Consumer Share Price\">Frequently Asked Questions on Honasa Consumer Share Price<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#Why_is_Honasa_Consumer_share_price_falling_today\" title=\"Why is Honasa Consumer share price falling today?\">Why is Honasa Consumer share price falling today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#Why_did_the_Fluence_Pharma_deal_fall_through\" title=\"Why did the Fluence Pharma deal fall through?\">Why did the Fluence Pharma deal fall through?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#What_is_Honasa_Consumers_nutraceutical_strategy\" title=\"What is Honasa Consumer&#8217;s nutraceutical strategy?\">What is Honasa Consumer&#8217;s nutraceutical strategy?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#What_is_Mamaearths_connection_to_Honasa_Consumer\" title=\"What is Mamaearth&#8217;s connection to Honasa Consumer?\">What is Mamaearth&#8217;s connection to Honasa Consumer?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#What_is_Honasa_Consumers_NSE_ticker\" title=\"What is Honasa Consumer&#8217;s NSE ticker?\">What is Honasa Consumer&#8217;s NSE ticker?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#What_are_closing_conditions_in_an_M_A_deal\" title=\"What are closing conditions in an M&amp;A deal?\">What are closing conditions in an M&amp;A deal?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026\/#Is_Honasa_Consumer_a_good_stock_to_buy_after_the_deal_termination\" title=\"Is Honasa Consumer a good stock to buy after the deal termination?\">Is Honasa Consumer a good stock to buy after the deal termination?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Honasa_Consumer_Mamaearth\"><\/span><strong>About Honasa Consumer (Mamaearth)<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Honasa Consumer Limited is the parent company of Mamaearth, one of India&#8217;s fastest-growing direct-to-consumer personal care brands. The company has expanded from its origins in baby and skincare products to a broader portfolio of beauty and personal care offerings under the Mamaearth, The Derma Co., Aqualogica, and Dr. Sheth&#8217;s brands, among others. Honasa Consumer trades on the NSE under the ticker HONASA.<\/p>\n<p>The company has been exploring growth beyond its core personal care business, including a foray into nutraceuticals, a category that covers health-oriented food supplements, vitamins, and functional nutrition products. The Fluence Pharma acquisition was positioned as a way to accelerate entry into nutraceuticals through an established player rather than building the capability organically from scratch.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Did_the_Fluence_Pharma_Deal_Fall_Through\"><\/span><strong>Why Did the Fluence Pharma Deal Fall Through?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Track Honasa Consumer live on the Univest Screener<\/strong><\/a><\/p>\n<p>The proposed acquisition of 58% in Fluence Pharma was terminated due to non-fulfilment of closing conditions specified in the Share Purchase Agreement. Closing conditions in M&amp;A transactions typically include requirements such as regulatory approvals, third-party consents, absence of material adverse changes in the target business, and confirmation that specific representations and warranties remain accurate. If any of these conditions are not satisfied by the agreed deadline, either party may have the right to exit the transaction.<\/p>\n<p>The company has not provided specific details about which closing conditions were not fulfilled. However, Honasa Consumer has signalled that the termination of the Fluence Pharma deal does not reflect a change in its strategic intent toward the nutraceutical category. The company explicitly stated it will continue to evaluate both organic and inorganic opportunities in the nutraceuticals space.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Market_Reaction_Why_Is_the_Stock_Falling\"><\/span><strong>Market Reaction: Why Is the Stock Falling?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 1.93% decline in Honasa Consumer share price reflects two interpretations that the market may be applying simultaneously. First, the deal termination creates uncertainty about the company&#8217;s nutraceutical expansion timeline. Second, the non-fulfilment of closing conditions raises questions about the due diligence process and whether there were undisclosed issues with Fluence Pharma that made it unsuitable as an acquisition target. Both interpretations weigh slightly on investor sentiment even though the termination itself avoids a potentially problematic acquisition.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Honasa_Consumer_Stock_Data\"><\/span><strong>Honasa Consumer Stock Data<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr>\n<th style=\"background: #1F4E79; color: #fff; padding: 8px 12px; text-align: left;\">Parameter<\/th>\n<th style=\"background: #1F4E79; color: #fff; padding: 8px 12px; text-align: left;\">Details<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">NSE Ticker<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">HONASA<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">Sector<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">FMCG \/ Consumer Goods \/ Beauty and Personal Care<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">CMP (Aug 26, 2026)<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">Rs 476.15<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">Change on Day<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">-Rs 9.35 (-1.93%)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">Intraday High<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">Rs 488.00<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">Intraday Low<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">Rs 475.30<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">Deal Terminated<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">58% stake acquisition in Fluence Pharma<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">Reason for Termination<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">Non-fulfilment of closing conditions under Share Purchase Agreement<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">Company&#8217;s Strategic Stance<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #ddd;\">Remains committed to nutraceutical strategy<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"What_Honasa_Consumers_Nutraceutical_Strategy_Means_Going_Forward\"><\/span><strong>What Honasa Consumer&#8217;s Nutraceutical Strategy Means Going Forward<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Despite the deal falling through, Honasa Consumer has affirmed that it remains committed to building a nutraceuticals business. The company has framed this as a strategic priority that it will pursue through other means. For investors, the key questions are: how long will it take to identify and execute an alternative acquisition or build organically, and what will the capital allocation look like for this expansion.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_for_Honasa_Consumer_Investors\"><\/span><strong>Key Risks for Honasa Consumer Investors<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Nutraceutical_Entry_Timeline_Delayed\"><\/span><strong>Nutraceutical Entry Timeline Delayed<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The failed Fluence Pharma deal delays Honasa Consumer&#8217;s nutraceutical ambitions. Building organically in this category from scratch typically requires significant time, capital, and consumer education investment.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Core_Business_Competition\"><\/span><strong>Core Business Competition<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Mamaearth&#8217;s core beauty and personal care business faces intensifying competition from both D2C brands and large established consumer companies that have strengthened their online and premium product offerings.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Honasa Consumer share price decline of 1.93% on August 26, 2026 is a measured reaction to the termination of the Fluence Pharma deal. While the deal&#8217;s failure delays the company&#8217;s nutraceutical strategy, Honasa Consumer&#8217;s management has affirmed that the category remains a strategic priority. The key development to watch is whether the company identifies and executes an alternative path into nutraceuticals, through acquisition, partnership, or organic development. Consult a SEBI-registered financial advisor before making any investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track live share prices and get daily stock insights.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Honasa_Consumer_Share_Price\"><\/span><strong>Frequently Asked Questions on Honasa Consumer Share Price<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Honasa_Consumer_share_price_falling_today\"><\/span><strong>Why is Honasa Consumer share price falling today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Honasa Consumer share price fell 1.93% to Rs 476.15 on August 26, 2026 after the company announced it has called off the proposed acquisition of a 58% stake in Fluence Pharma. The deal was terminated due to non-fulfilment of closing conditions under the Share Purchase Agreement.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_the_Fluence_Pharma_deal_fall_through\"><\/span><strong>Why did the Fluence Pharma deal fall through?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Honasa Consumer acquisition of 58% of Fluence Pharma was terminated because the closing conditions specified in the Share Purchase Agreement were not fulfilled. Closing conditions in M&amp;A transactions include regulatory approvals, representations and warranties remaining accurate, and other deal-specific requirements. The company has not disclosed which specific conditions were not met.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Honasa_Consumers_nutraceutical_strategy\"><\/span><strong>What is Honasa Consumer&#8217;s nutraceutical strategy?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Honasa Consumer has been exploring entry into the nutraceuticals segment, which covers health-oriented food supplements, vitamins, and functional nutrition products. The company intended to enter the category through the Fluence Pharma acquisition. Following the deal termination, Honasa Consumer stated it remains committed to the nutraceuticals category and will continue evaluating organic and inorganic opportunities.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Mamaearths_connection_to_Honasa_Consumer\"><\/span><strong>What is Mamaearth&#8217;s connection to Honasa Consumer?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Honasa Consumer Limited is the parent company of Mamaearth, India&#8217;s popular D2C personal care brand. Honasa Consumer also owns other brands including The Derma Co., Aqualogica, and Dr. Sheth&#8217;s. The company trades on the NSE under the ticker HONASA.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Honasa_Consumers_NSE_ticker\"><\/span><strong>What is Honasa Consumer&#8217;s NSE ticker?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Honasa Consumer Limited trades on the NSE under the ticker symbol HONASA. The company is India&#8217;s leading D2C consumer goods company, best known for its Mamaearth brand.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_closing_conditions_in_an_M_A_deal\"><\/span><strong>What are closing conditions in an M&amp;A deal?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Closing conditions in a merger and acquisition transaction are a list of requirements that both parties agree must be met before the deal can be formally completed (closed). These typically include regulatory approvals, no material adverse changes at the target company, accuracy of representations and warranties, and third-party consents. If any condition is not met, the agreement may allow either party to terminate the deal.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Honasa_Consumer_a_good_stock_to_buy_after_the_deal_termination\"><\/span><strong>Is Honasa Consumer a good stock to buy after the deal termination?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The deal termination adds some uncertainty to Honasa Consumer&#8217;s nutraceutical growth plans. However, the core beauty and personal care business remains intact. Investment suitability depends on the company&#8217;s core business performance, growth strategy execution, and valuation. This article does not constitute investment advice. Consult a SEBI-registered financial advisor.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Honasa Consumer (Mamaearth) share price fell 1.93% on Aug 26 after calling off the proposed 58% stake acquisition in Fluence Pharma due to non-fulfilment of closing conditions.<\/p>\n","protected":false},"author":28,"featured_media":219792,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[3802,3818],"class_list":["post-219793","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-news","tag-share-price-falling"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["219792"],"_edit_lock":["1787735861:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["24"],"rank_math_seo_score":["70"],"rank_math_title":["Honasa Consumer Share Price Falls on Fluence Pharma Deal Exit"],"rank_math_description":["Honasa Consumer (Mamaearth) share price fell 1.93% to Rs 476.15 on Aug 26 after calling off the proposed 58% stake acquisition in Fluence Pharma due to non-fulfilment of closing conditions."],"rank_math_focus_keyword":["Honasa Consumer share price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["40024"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/honasa-consumer-share-price-fluence-pharma-deal-exit-2026.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/219793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=219793"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/219793\/revisions"}],"predecessor-version":[{"id":219812,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/219793\/revisions\/219812"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/219792"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=219793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=219793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=219793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}